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Abstract
One of the great challenges in the post-genomic era is to decipher the underlying principles governing the dynamics of
biological responses. As modulating gene expression levels is among the key regulatory responses of an organism to
changes in its environment, identifying biologically relevant transcriptional regulators and their putative regulatory
interactions with target genes is an essential step towards studying the complex dynamics of transcriptional regulation. We
present an analysis that integrates various computational and biological aspects to explore the transcriptional regulation of
systemic inflammatory responses through a human endotoxemia model. Given a high-dimensional transcriptional profiling
dataset from human blood leukocytes, an elementary set of temporal dynamic responses which capture the essence of a
pro-inflammatory phase, a counter-regulatory response and a dysregulation in leukocyte bioenergetics has been extracted.
Upon identification of these expression patterns, fourteen inflammation-specific gene batteries that represent groups of
hypothetically ‘coregulated’ genes are proposed. Subsequently, statistically significant cis-regulatory modules (CRMs) are
identified and decomposed into a list of critical transcription factors (34) that are validated largely on primary literature.
Finally, our analysis further allows for the construction of a dynamic representation of the temporal transcriptional
regulatory program across the host, deciphering possible combinatorial interactions among factors under which they might
be active. Although much remains to be explored, this study has computationally identified key transcription factors and
proposed a putative time-dependent transcriptional regulatory program associated with critical transcriptional
inflammatory responses. These results provide a solid foundation for future investigations to elucidate the underlying
transcriptional regulatory mechanisms under the host inflammatory response. Also, the assumption that coexpressed genes
that are functionally relevant are more likely to share some common transcriptional regulatory mechanism seems to be
promising, making the proposed framework become essential in unravelling context-specific transcriptional regulatory
interactions underlying diverse mammalian biological processes.
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Introduction
Inflammation and activation of innate immunity are essential
defense responses against invading pathogens and endogenous
danger signals. The innate immune response involves the initial
recognition of conserved pathogen-associated molecular patterns
by members of the Toll-like receptor (TLR) family [1]. The
exposure of the host to gram negative bacteria, simulated by
lipopolysaccharide (LPS) recognized by TLR-4, triggers intracel-
lular signalling cascades which eventually release a lot of pro- and
anti- inflammatory cytokines [2]. While the host inflammatory
response is essential to resolve the infection or repair the damage
and restore the system homeostasis, it also plays a central
pathogenic role in a wide spectrum of diseases including sepsis
[3]. Under healthy circumstances, inflammatory responses are
activated, clear the pathogen in the case of infection, initialize a
repair process and then abate [4]. However when anti-inflamma-
tory processes fail, an amplified inflammation can turn what is
normally a beneficial reparative process into a detrimental
physiological state with severe, uncontrolled systemic inflamma-
tion [5].
Studies involving experimental human endotoxemia have
reported rapid intravenous infusion in doses of 2–4 ng/kg body
weight, which effectively induces an acute systemic inflammatory
condition that mimics the early flow phase of injury and infection
[6,7,8,9,10]. In human peripheral blood leukocytes, intravenous
administration of endotoxin elicits dynamic and reproducible
changes in the circulating leukocyte population as well as
significant changes in blood leukocyte gene expression patterns
[11]. This perturbation of leukocyte gene expression involves
several thousands of transcripts and accompanies the systemic
physiological responses during inflammation, which peaks ,4–
6 hours after endotoxin exposure and resolves within 24 hours,
compatible with a large and dynamic regulatory network.
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activate transcription factors (TFs) through mechanisms such as
phosphorylation or dimerization. Activated complexes are subse-
quently translocated into the nucleus and bind to the promoter
region of target genes in the genome in order to activate or repress
gene expression [12]. It is hypothesized that this regulation process
is mainly controlled by the interplay between TFs and their
corresponding transcription factor binding sites (TFBSs) on the
proximal promoters of the target genes [13,14,15]. Recent
technological developments have enabled the ability to broadly
assess TF activities at a genome-wide scale. However, there is still
no transcription factor-focused method that enables monitoring of
all TFs at a time; technologies such as Chip-on-chip [16,17],
SELEX [18,19] can identify all DNA binding sites occupied by a
single TF given a condition. In order to compensate for this
inability, computational techniques have become an essential tool
in predicting putative TFBSs at a large scale [20,21].
Due to the fact that TFs in higher organisms regulate gene
expression in a combinatorial manner rather than in isolation
[22,23] and that TFBSs tend to form clusters of binding sites,
known as cis-regulatory modules (CRMs) [24,25], computational
methods have shifted towards discovering CRMs instead of a
single TFBS. A cis-regulatory module is generally considered as the
smallest functional regulatory unit [26]. From a computational
standpoint, such module is mainly characterized by two factors: (i)
composition which consists of a set of non-overlapping binding
sites of TFs on the control regions of a gene and (ii) structural
constraints that take into account the strand orientation to which
TFs bind, the order and the distance between successive binding
sites [27]. A variety of methods have been proposed to search for
CRMs that include the structural constraints (FrameWorker [28],
CMA [29]) or without the structural constraints (CREME [30],
ModuleMiner [31], Stubb [32]). Some methods attempt to
incorporate a priori knowledge of CRMs (HexDiff [33], ESPERR
[34,35]) to increase the specificity of the prediction while some
others are purely computationally discovery of CRMs (CisModule
[36], CSam and D2Z-set [37]).
However, given a methodology to search for CRMs, a critical
issue in predicting functional binding sites is identifying a set of
relevant promoters that share common cis-regulatory modules or
alternatively a set of genes that are potentially coregulated [38]. As
such it is more appropriate to explore the concept of ‘gene battery’
originally proposed by Britten and Davidson [39] and has been
further explored in the literature [40,41,42,43]. A gene battery
refers to a group of genes that are coordinately expressed and/or
functionally coupled since their regulatory regions respond to the
same transcriptional signals [37,44]. With the assumption that
genes in a gene battery are involved in key biological processes,
recognized CRMs will consist of putative functional binding sites
that are associated with essential transcriptional regulators. Yet, in
higher eukaryotes especially in humans the problem turns to be
much more difficult. One of the most critical issues is to determine
which genes belong to the same gene battery. Prior studies assume
that either coexpressed genes [45,46,47] or genes that belong to
the same biological process [48,49] could be governed by some
common regulatory mechanism. However, recent evidence
suggests that co-expression or co-function alone is not sufficient
to infer the existence of common regulatory mechanisms [50,51].
Oftentimes co-expressed genes can participate in a diverse array of
biological functions while functionally-relevant genes can be
characterized by different expression patterns [52,53]. Predicated
upon these, in this study we explore the possibility that genes that
are both co-expressed and functionally-relevant may be more
likely to be co-regulated. Since genes within the same pathway
encode for a set of interacting proteins, they are more likely to be
governed by some common regulatory mechanism [54]. There-
fore, the unifying hypothesis of this study is that genes that
participate in the same pathway are functional relevant.
In this study, given the transcriptional profiling analysis of
human blood leukocytes we hypothesized that genes that are most
responsive to an external perturbation (endotoxin) and have
concerted changes in their expression profiles are governed by
some common regulatory mechanism. Based on our prior work,
high-dimensional microarray data are decomposed into a
comprehensive set of temporal responses that, in the case of
transient human endotoxemia, capture the essence of a pro-
inflammatory phase, a counter-regulatory response as well as a
dysregulation in leukocyte bioenergetics [55]. Upon identification
of these patterns, a number of inflammation-specific pathways are
selected by evaluating the enrichment of the corresponding subsets
and thereby defining a putative set of ‘coregulated’ genes. The
CRM-se arching process, similar to FrameWorker [28], is
proposed with a novel heuristic to address the issue related to
multiple alternative promoters in eukaryotic genes. The definition
of CRM structural constraints has been adjusted so that no
parameter is required for the searching process except for the
statistically significant threshold for the CRM selection. Further-
more, motivated by the work of Schones et al. [56] a pre-
compilation step is performed by converting all promoter
sequences into a set of corresponding promoter profiles of binding
sites improving the estimation of the statistical significance of
recognized CRMs. Overall, the present study aims to computa-
tionally identify transcription factors that are crucial to the
dynamics of essential physiological processes associated with the
acute human inflammatory response and provides significant
insights into putative transcriptional regulatory mechanisms that
underlie gene expression. Computational results were verified
primarily based on available literature.
Results
Identification of putatively ‘coregulated’ genes
Given the assumption that genes that are co-expressed and
functionally relevant are more likely to be co-regulated, we first
identify significant expression patterns from in vivo human
transcriptional data [11]. Based on 3,269 differentially expressed
probesets, we explored the potential of our prior work to identify
highly coexpressed genes [55]. Specifically, the algorithm performs
a consensus clustering and a trivial cluster removal procedure
resulting in four expression patterns that describe the dynamic
evolution of endotoxin-induced human inflammation (Figure 1).
The ‘early-up’ pattern consists of genes that are involved in critical
pro-inflammatory processes (e.g. TNF, NFkBIA, C-X-C motifs –
CXCL1, CXCL2, and CCL20). The ‘middle-up’ pattern
represents an increased expression of genes with the peak at
4 hrs post-endotoxin administration, containing inflammatory-
relevant signaling pathways such as Apoptosis, Toll like receptor
(TLR) signaling. The ‘late-up’ pattern characterizes anti-inflam-
matory processes and the ‘down’ pattern which is the most
populated expression motif is characterized by genes involved in
cellular bio-energetic processes e.g. oxidative phosphorylation,
ribosome biogenesis and assembly.
Since pathways are robust and flexible enough to ensure cell
survival under environmental changes, the corresponding genes
are more likely to be characterized by a stronger coherency rather
than those in a gene ontology (GO) definition. Based on the
hypothesis that genes encoding a set of related proteins are more
likely to be transcribed under some common regulatory mecha-
Endotoxemia Regulation
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pathways (KEGG database) rather than GO terms. All genes that
participate in the same pathway are considered to be functionally
relevant are related [53]. In each expression pattern, we select
statistically inflammatory relevant significant pathways (p-val-
ue,0.05) based on literature information [55]. Accordingly,
fourteen sets of genes that belong to a specific pathway and a
pattern of gene expression are extracted. We further assume that
these groups of genes represent gene batteries, and hereby are
more likely to be coregulated (Table 1).
Statistical significance of common CRMs
Within a gene battery, CRMs that are present on the control
regions of corresponding genes above a frequency threshold (e.g.
d=70% of the number of genes) are considered as common
CRMs. However, such CRMs can also be overrepresented in
random gene sets. Therefore, in order to restrict the false positive
matches and increase the statistical power of our method, we
estimate the hyper-geometric p-values of common CRMs vs. a
background set and only select those CRMs whose p-values
exceed a pre-defined statistically significance threshold (e.g. 10
24).
However, this threshold is very sensitive to the size of the gene
battery and thus a uniform significance threshold cannot be
applied for all gene batteries. As a result, we developed a heuristic
procedure for estimating the significance threshold of common
CRMs with respect to the size of gene batteries. The procedure is
repeated 100 times for each N-size gene-set (N=4, 5…, 20). At
each iteration, the algorithm randomly selects N genes from the
background set, searches for common CRMs that are present on
the promoters of these genes (d=0.7), estimates the statistical
significance (p-values) for each CRM (see materials and methods),
and records the minimum one. In this study, we choose the
approximate values of the mean of these minimum p-values to set
the criterion for the statistical significance of CRMs in a gene
battery with size N (Figure 2). Consequently, for each gene
battery only those CRMs that are identified with p-values less than
the corresponding p-value thresholds are used to infer relevant
transcription factors (see Data S1, sheet ‘p-value’).
Identification of inflammation-relevant transcriptional
regulators
One of the key features in our analysis is the identification of
significantly overrepresented CRMs in each gene battery (see
Materials and methods and Algorithms S1). Based on the size of a
gene battery, a corresponding significance threshold is applied to
select statistically significant CRMs. Since these recognized CRMs
are located on the control regions of many putatively coregulated
genes (i.e. a gene battery), they are likely to be composed of
functional binding sites that are activated upon the initiation of the
transcriptional machinery. We therefore decompose these CRMs
into a list of TFBSs to infer associated TFs which can be
considered as relevant transcriptional regulators of the corre-
sponding gene battery. In particular, TFs that are present with the
high frequency among gene batteries (at least three times across
fourteen gene batteries) are assumed to play a key role in the
biological process (Table 2). We identify 34 transcription factors
(TFs) relevant to the human inflammatory responses, of which
around 25% has been experimentally shown to be involved in the
inflammatory and/or immune response based on literature
evidence (discussed below) and more than half of the remaining
have been computationally shown to play a critical role in the
regulation of immune system [57] (see Data S1, sheet ‘CRMs’,
‘TFs’, and ‘Middle-up TLR’).
Putative temporal program of transcriptional regulation
The administration of a low dose of endotoxin to human
subjects elicits dynamic and reproducible changes in the
circulating leukocyte population by altering the expression level
of numerous genes. Since the host response to endotoxin evolves
Figure 1. Critical responses to human inflammation. Gene expression patterns selected from the LPS dataset, including early up – 182
probesets (red), middle up – 119 probesets (green), late up – 284 probesets (blue), and down – 1,118 probesets (magenta); totally 1,730 selected
probesets over 3,269. Top-left is the average expression profiles of these patterns; bottom-left is the corresponding heat-map; and the rest are
expression profiles of selected genes in four patterns (the horizontal axis is six time-points (0, 2, 4, 6, 9, 24 hours) and the vertical axis is the intensity
of mRNA levels).
doi:10.1371/journal.pone.0018889.g001
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the transcriptional regulatory program (Figure 3). Due to the fact
that transcription factors are characterized by pleiotropic effects
[58], it is also reasonable to anticipate a significant overlap among
sets of transcriptional regulators across various biological process-
es. On the other hand, our results also illustrate the phenomenon
in which genes involved in the same function (pathway) may
exhibit different expression patterns and genes within an
expression pattern can participate in different functions, implying
that there are different regulatory mechanisms regulating genes in
the same function or in the same expression pattern. Along with
this dynamic response, the regulatory mechanisms can also be
Table 1. Data information and inflammation-relevant significant functions.
Expression data (3,269 probesets
*) Relevant significant functions (p-value,0.05)
Patterns
# of probesets
(Total: 1703)
# of genes
+
(Total: 1213) Pathways (KEGG) Corresponding selected genes
Early-up 182 141 Apoptosis
1 il1a, il1b, nfkbia, tnf
Cytokine-cytokine receptor interaction
1 ccl20,ccl4, cxcl1, cxcl2, il1a, il1b, il8, inhbb, tnf
Toll-like receptor signaling pathway
1 ccl4, il1b,il8, map2k6, nfkbia, tnf
Middle-up 119 88 Apoptosis
1 casp10, cflar, fas, irak3, myd88, nfkb1, nfkb2, rela
Toll-like receptor signaling pathway
1 myd88, nfkb1, nfkb2, rela
Late-up 284 185 Apoptosis
1 casp8, il1r1, il1rap, irak4, pik3cg, tnfrsf10c, tnfsf10
Cytokine-cytokine receptor interaction
1 ccr1, csf3r, il10rb, il13ra1, il1r1, il1rap, il8ra, il8rb, tnfrsf10c, tnfsf10
Toll-like receptor signaling pathway
1 casp8, irak4, pik3cg, tlr1, tlr5, tlr8
Jak-STAT signaling pathway
1 csf3r, il10rb, il13ra1, pik3cg, stat2, stat5b
Down 1118 799 Citrate cycle (TCA cycle)
2 acly, idh2, idh3a, mdh1, mdh2, suclg2
Pyrimidine metabolism
2 dck, dctd, dut, entpd6, pole3, polr2b, polr2e, polr2k, rpa1, uckl1
Pyruvate metabolism
2 akr1b1, glo1, ldhb, mdh1, mdh2, pdhb
Ribosome
1 fau, rpl10a, rpl12, rpl13a, rpl14, rpl18, rpl24, rpl27, rpl27a, rpl29, rpl3,
rpl36a, rpl36al, rpl37a, rpl38, rpl8, rps2, rps24, rps7, rps9
Oxidative phosphorylation
2 atp5a1, atp5b, atp5f1, atp5g1, atp5g2, atp5g3, atp5i, atp5h, atp5j2,
atp5l, atp5o, atp61f, cox4i1, cox5a, cox6c, cox7c, cyc1, nduf1,
ndufa13, ndufa3,ndufa4, ndufa5, ndufa6, ndufab1, ndufb2, ndufb4,
ndufb5, ndufb8, ndufc2, ndufs4, ndufs5, ndufs6, ndufs7, ndufs8,
ppa2, ucrc, uqcrb, uqcrc2, uqcrh, uqcrq
*: 3,269 significantly differentially expressed probesets were selected by ANOVA (p-value,10
24) from the total 44,924 probesets;
+: the number of corresponding genes with promoter annotation in Genomatix;
1: regulatory pathways;
2: metabolic pathways.
doi:10.1371/journal.pone.0018889.t001
Figure 2. Statistical significance thresholds of CRMs. A procedure randomly picks a gene-set with N genes from the background and search
for common CRMs (d=0.7) in that gene-set. The statistical significant p-value for each CRM is estimated and the minimum one is reported. Each point
in the blue curve is a transformed value of the mean of the minimum p-values of CRMs in 100 times running the procedure for the corresponding k.
Approximately, the red curve shows which thresholds should be used for the non-random cases. After N=14 genes, only one threshold is used to
ensure the significance (p-value=0.01).
doi:10.1371/journal.pone.0018889.g002
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transcriptional network topology. Additionally, the results also
reflect the phenomenon that a gene can participate in various
functions and thus be regulated by different sets of transcriptional
regulators based on the context (e.g. TNF, MYD88).
Discussion
Functional characterization of inflammation-relevant
pathways
Upon identification of four significant patterns of gene
expression, a number of inflammation-specific pathways are
selected by evaluating the enrichment of corresponding subsets
in inflammation-specific pathways, including Toll-like receptor
signaling, Cytokine-Cytokine receptor interaction, Apoptosis and
JAK-STAT signaling cascade, etc. (Table 1). It is now well
established that Toll like receptor signaling pathway is the first arm
of the host defence system that is activated when endotoxin is
recognized by pathogen recognition receptors [59]. During the
recognition process, LPS binds and interacts with its signaling
receptor (TLR4) which triggers a signal transduction cascade
essential for the up-regulation of several pro-inflammatory
mediators [60]. Such mediators including cytokines and chemo-
kines interact with their appropriate receptors, giving rise to the
Cytokine-Cytokine receptor signaling pathway that amplifies and
propagates the inflammatory reaction throughout the cell until the
system restores homeostasis [61]. Therefore, both Toll like
receptor signaling and Cytokine-Cytokine receptor interaction
pathways play a pivotal role in the pro-inflammatory response.
Complementary to this, considerable attention has been given to
the role of an excessive death of immune effector cells (apoptotic
cells) during the progression of an aberrant inflammatory response
[62]. The nature of apoptosis as a rectifying process has led
researchers to the realization that identifying mediators that are
critical in regulating the apoptotic-inflammatory imbalance might
prove beneficial in treating human sepsis [63]. It is therefore
reasonable to assume that apoptosis also plays a critical role in the
endotoxin-induced inflammatory process. Along similar lines,
JAK-STAT cascade is another highly enriched inflammation-
specific pathway that exerts anti-inflammatory properties. Accord-
ingly, recent data provide evidence that a STAT pathway from a
receptor signaling system is a major determinant of key regulatory
systems including feedback loops such as SOCS induction which
subsequently suppresses the early induced Toll like receptor and
cytokine signaling [64,65]. Endotoxin–induced inflammation also
causes a widespread suppression at the transcriptional response
level of genes involved in mitochondrial energy production
(Oxidative phosphorylation) and protein synthesis machinery
(Ribosome). Such dysregulation in leukocyte bioenergetics togeth-
er with persistent decrease in mitochondrial activity can lead to
reduced cellular metabolism [66], resulting in the participation of
a number of critical metabolic pathways, e.g. Citrate cycle,
Pyrimidine and Pyruvate metabolism.
While comparing the inflammatory relevant pathways across
expression patterns, we observe that there is a dynamic evolution
of these pathways during the propagation of LPS signaling. For
example, Toll like receptor signaling appears to be significantly
enriched with a diverse array of genes that are early, middle or late
up-regulated. From a biological standpoint, since the recognition
process of LPS from its signaling receptor (TLR4) leads to the
transcriptional activation of cytokines and chemokines (e.g. TNF,
IL1B, CCL4), the early transcriptional event (t=2 h) can possibly
reflect this initiating process [67] while at later stages of the
inflammatory reaction (t=4 h), the effect of LPS has been
translated into the signal transduction cascade mediated by the
up-regulated cytokines. Such a signal transduction cascade is likely
to be initiated by the conserved Toll/IL1 receptor (TIR) signaling
domain [65] explaining the presence of TLR signaling in the
early–up response (t=2 h). Meanwhile, the presence of this
pathway in the middle-up response (t=4 h) is indicative for
Table 2. Critical transcription factors in human endotoxemia model.
No. Patterns Functions Transcription factors
1 Early-up Apoptosis BRNF, CLOX, E2FF, EKLF, ETSF, HEAT, HOXF, IRFF, MAZF, MYT1, NFKB, RXRF, SORY, SP1F
2 Middle-up Apoptosis AP4R, CREB, E2FF, ETSF, GATA, HEAT, MAZF, MZF1, NFKB, NKXH, PAX6, SP1F, ZBPF
3 Late-up Apoptosis ATBF, BRNF, CLOX, EBOX, ETSF, FKHD, GATA, HOMF, HOXF, IRFF, NKXH, OCT1, PARF, SORY,
STAT, TBPF
4 Early-up Toll-like receptor signaling pathway EKLF, HEAT, MAZF, MYT1, SP1F
5 Middle-up Toll-like receptor signaling pathway CREB, E2FF, EGRF, EKLF, ETSF, EVI1, HEAT, MAZF, MYBL, MZF1, NFKB, NR2F, PAX6, SORY,
SP1F, STAT, ZBPF
6 Late-up Toll-like receptor signaling pathway AP4R, ATBF, BRNF, CLOX, ETSF, EVI1, FKHD, GATA, HOMF, HOXF, IRFF, MEF2, NKXH, OCT1,
PARF, SORY, STAT, TBPF
7 Early-up Cytokine-cytokine receptor interaction SORY, TBPF
8 Late-up Cytokine-cytokine receptor interaction AP4R, CLOX, EBOX, ETSF, EVI1, FKHD, GATA, HEAT, HOMF, HOXF, IRFF, MAZF, MEF2, NFKB,
NR2F, OCT1, PARF, PAX6, RXRF, SORY, SP1F, TBPF
9 Late-up Jak-STAT signaling pathway AP4R, BRNF, CLOX, E2FF, EGRF, ETSF, HEAT, HOMF, HOXF, MAZF, MZF1, RXRF, SP1F, ZBPF
10 Down Citrate cycle (TCA cycle) ATBF, BRNF, EGRF, ETSF, FKHD, HEAT, HOMF, HOXF, MAZF, MEF2, MYBL, MYT1, MZF1,
NR2F, RXRF, SP1F, STAT, TBPF, ZBPF
11 Down Pyrimidine metabolism CREB, E2FF, EBOX, ETSF, IRFF, MYBL, SP1F, ZBPF
12 Down Pyruvate metabolism HEAT
*
13 Down Ribosome E2FF, ETSF, RXRF
14 Down Oxidative phosphorylation None
*: present in cis-regulatory module ‘+HEAT__+NRF1__+NRSF’.
doi:10.1371/journal.pone.0018889.t002
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(e.g. NFkB) essential for mediating the host response at later time
events. Regarding the late up-regulated transcriptional event
(t=6 h), the system activates the expression of various genes that
can effectively constraint the inflammatory response. Thus, anti-
inflammatory mechanisms involve either the activation of JAK-
STAT cascade (e.g. IL10RB, IL13RA1), or the increased
expression of receptors (e.g. IL1R1, IL8RA, CCR1) that intend
to replace and compensate for those that have been consumed
during pro-inflammation [68]. Therefore, this cascade of events
sheds significant insight on the dynamic evolution of critical pro-
inflammatory pathways including TLR signaling, Apoptosis and
Cytokine-Cytokine interaction signaling.
Biological characterization of identified transcription
factors
Predicated upon the hypothesis that subsets of co-expressed
genes involved in the same biological pathway are more likely to
be co-regulated, their transcriptional regulators are computation-
ally predicted (Table 2). There is considerable evidence indicating
the inflammatory relevance of the aforementioned inferred
transcription factors including MEF2 [69], GATA [70], OCT1
[71], FKHD [72], ETSF [73], IRFF [74], NFKB [75] and CREB
[76]. Specifically, the myocyte enhancer factor 2 (MEF2)
transcription factor plays a central role in the transmission of
extracellular signals to the genome and in the activation of genetic
programs that control cell differentiation, proliferation, survival
and apoptosis [77]. In addition to this, MEF2 proteins serve as the
endpoints for multiple inflammatory signaling pathways including
mitogen-activated protein kinase signaling pathway (MAPK) and
thereby confer signal-responsiveness to downstream target genes
[78]. Also, evidence [79,80] suggests the dual role of MAPK
signaling and thereby the activation of MEF2 transcription factor
under TLR4 and Cytokine dependent mechanism. Furthermore,
the octamer transcription factor 21 (OCT-1) has also been shown
to function as a stress sensor modulating the activity of genes
important for the cellular response to stress [81]. Although OCT-1
is a ubiquitous transcription factor, it has recently been
Figure 3. Putative temporal regulatory program in human endotoxemia plus schematic illustration of the integrated
computational framework. The clustering and selection step extracts a ‘clusterable’ subset of differentially expressed probesets and cluster it
into a number of expression patterns. Subsequently, pathway enrichment is performed in each pattern and relevant significant pathways are selected
based on literature information. The process of CRM searching is then applied to each gene battery which is a group of genes that belong to an
expression pattern and a particular pathway. Eventually, 34 TFs are identified as human inflammation-relevant transcriptional regulators. The results
show a highly dynamic perspective of regulation and interactions between genes, functions, and TF across the time.
doi:10.1371/journal.pone.0018889.g003
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ment in the apoptosis signaling [82]. Additional studies [83]
document the involvement of octamer binding transcription
factors (OCT-1) in regulating the expression of TLR4 in humans;
thus making it a critical regulator of Toll like receptor signaling.
Furthermore, Forkhead Transcription Factors (FKHD) also play a
major role in the control of apoptosis perhaps by affecting the
transcription of the gene encoding FASL [84]. Since these
regulators can be the substrate of the protein kinase B (Akt)
preventing their nuclear translocation, it is expected that FKHD
regulators promote cellular survival and thereby control the
apoptotic machinery [85]. Moreover, IFN regulatory factors
(IRFF) are a family of transcription factors that regulate expression
of various pro-inflammatory and anti-inflammatory genes. Re-
search findings reveal a critical role for these interferon regulatory
proteins in the control of apoptosis [86,87] while it has become
evident [88,89] that such regulators are also essential for TLR
gene expression including the trans-acting factors, IRF-1 and IRF-
2. This implies that in addition to up-regulation of pro-
inflammatory gene expression, TLR stimulation also results in
modulation of TLR gene expression itself via interferon transcrip-
tion factors.
One of the most important cellular factors involved in the
regulation of the host innate immune response is the nuclear factor
(NF)-kB which can be activated by a variety of stimuli including
bacterial products, inflammatory cytokines and growth factors
[75,90]. NF-kB is a pleiotropic transcription factor involved in the
inducible expression of a diverse array of genes. As such, activation
of the NF-kB signalling module involves not only the early up-
regulation of pro-inflammatory cytokines but also the transcrip-
tional control of apoptosis [91]. Oftentimes, transcriptional
regulation requires the participation of several transcriptional
factors through protein-protein interactions, known as transcrip-
tional co-activators or co-repressors. For example, NF-kB
encompasses an important family of inducible transcriptional
activators critical in the regulation of the gene expression in
response to injury and inflammatory stimuli. As such, the CREB-
binding protein has been identified as co-activator of the NF-kB
component p65 and might play an important role in the cytokine-
induced expression of various immune and inflammatory genes
[92]. Such observations emphasize the role of the CREB regulator
in pro-inflammatory signaling pathways including TLR signaling
pathway. Further evidence [93] confers the involvement of over-
expressed CREB in inducing apoptosis while the control of FASL
induction which mediates programmed cell death in human T
lymphocytes [94] appears to be accomplished through a series of
regulatory interactions that implicate the role of NF-kB and
CREB/ATF pathways [95].
Additionally, there is considerable evidence indicating the role
of the early growth response-1 (member of EGR family) in
regulating endotoxin induced SOCS-1 transcription [96]. SOCS-1
has been identified as a critical regulator of both adaptive cytokine
signaling and innate immune responses and therefore understand-
ing its transcriptional regulation under inflammatory conditions
will no doubt be critical in understanding its role in limiting
inflammatory responses [97]. Interestingly, these results demon-
strate an important role of regulatory members of EGR family in
regulating the endotoxin induced activity of the SOCS-1
promoter; thereby validating its presence in our computational
predictions. In addition to transcriptional regulation of the anti-
inflammatory SOCS family, recent data [98] also discussed a
critical role of IL10 signaling in SOCS-3 expression which
provides for feedback attenuation of cytokine induced immune
responses. Other studies [99] document that SP1 regulator may be
a central mediator of IL10 induction and thereby it may also play
a crucial role in cytokine homeostasis. Accordingly, our method
captures the family of stimulating protein 1 (SP1F) as a putative
regulator in late phase (resolution) of the inflammatory response.
On the other hand, we also observe a significant overlap across
various biological processes while comparing these sets of TFs but
it is reasonable since transcription factors are characterized by
pleiotropic effects [58] (Figure 4). TLR signaling appears to be the
principal pathway that initiates the host response to endotoxin and
via the cross-talk among other pathways (e.g. Apoptosis, JAK-
STAT) amplifies and propagates the inflammatory reaction
providing for complex non-linear responses [100].
Dynamic transcriptional regulatory program
The transcriptional regulatory program can potentially show a
dynamic reorganization over time. In order to get a dynamic
perspective, we focus on the apoptotic regulatory program as an
illustration. Apoptosis is tightly regulated process that mainly
responds to the initial stimulus followed by a cascade of events that
involve the initiation and signal transduction phase. The initiation
or preparation phase involves the activation of surface death
receptors (extrinsic pathway); for example, TNFR responds to
appropriate ligands (e.g. TNF), triggering downstream a signal
transduction phase which eventually converges to the activation of
effector caspases [101]. On the other hand, programmed cell
death is regulated by caspase inhibitors which attenuate apoptosis.
Such events would therefore reflect the early, middle and late
apoptosis respectively (Figure 5).
Despite the identification of condition (time) specific regulators,
the pleiotropic role of some transcription factors across multiple
conditions is also observed. Accordingly, the myeloid transcription
factor, MYT1, appears to be a critical pro-apoptotic regulator that
affects the progression of the early stage apoptosis. Although
considerable evidence [102,103,104] indicates the role of MYT1
in cell cycle regulation through induction of Cdc2 activity, further
Figure 4. Pleiotropic effects of transcription factors across
biological processes. Venn diagram shows pair-wise transcription
factor combinations that overlap between the inflammatory relevant
pathways (*: not present as TFs that regulate Toll-like receptor signaling
pathway in this case).
doi:10.1371/journal.pone.0018889.g004
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kinases in apoptosis induced by various stimuli. Therefore, such
observation implies the possible involvement of Cdc2 regulators
including MYT1 in enhancing programmed cell death during the
early pro-inflammatory phase (early apoptosis). In addition to
regulation of apoptosis, E2F family of DNA binding proteins has
also been shown to have the ability to induce not only cell cycle
but also programmed cell death [106,107] by regulating the
activation of pro-apoptotic genes as seen in Figure 5. Such
evidence allows the identification of transcription factors with
multifunctional capabilities essential for modifying coupled cellular
processes including cell cycle and apoptotic behavior [102].
The retinoid X receptors (RXR) play a critical role in apoptosis.
These proteins act functionally as either homodimers or
heterodimers with other members of the nuclear hormones
receptor family such as retinoid acid receptors (RAR) and
peroxisome proliferators activated receptor (PPAR), which are
all associated with the regulation of inflammation [108]. In
particular, the interplay between RXR and RAR receptors has
been shown to induce apoptosis which validates its role as a time
specific regulator of early apoptosis [109,110]. Despite the
conventional role of NF-kB as anti-apoptotic [111], our results
indicate its putative role in mediating cell death by transcription-
ally up-regulating early and middle pro-apoptotic genes. Such
antagonistic duality for the regulatory role of NF-kB has been
recently outlined in [112] signifying its involvement in a pro-
apoptotic fashion by up-regulating the expression of Fas. Reduced
Fas expression followed by a reduction in apoptosis was also
observed upon endotoxin challenge in relA
2/2 (deficient) rodents
suggesting a novel pro-apoptotic function for this protein in Fas
induced cell death [113].
Putative regulators of middle and late apoptosis, including both
pro- and anti-apoptotic transcription factors have been identified
which aim at enhancing and controlling programmed cell death
respectively. As such, activating binding protein (AP4R) which
according to our results is present in middle apoptosis, has been
shown to regulate the expression level of various caspases [114].
On the other hand, CREB binding protein has been shown to play
a pivotal role in rescuing from apoptosis promoting cell survival
via the induction of anti-apoptotic proteins [115,116] while
evidence [117] documents GATA as a novel MAPK substrate
that plays an essential role in a cytokine mediated anti-apoptotic
response. Based on our predictions GATA appears to be a
significant regulator during late apoptosis conferring its role as
anti-apoptotic protein. Since the late transcriptional event has
been previously identified as a critical anti-inflammatory compo-
nent, it is expected the regulators of late apoptosis to participate in
controlling apoptosis by transcriptionally activating anti-apoptotic
genes such as PIK3CG [118]. For example, studies on the STAT
regulator have shown that it exerts an anti-apoptotic function
required for maintenance of neutrophil homeostasis [119].
Furthermore, FKHD proteins also negatively affect apoptosis
signaling through Akt signaling that is implicated in promoting cell
survival [85,120]. Both STAT and FKHD binding proteins exert
direct regulatory links on the late apoptosis (Figure 5).
On the other hand, regarding the case that genes are involved in
different functions within a particular expression pattern, a
possibility relevant to alternative promoter usage can be suggested
[50,51]. Besides alternative promoters activated upon tissue-
specific or condition-specific context, it is possible to hypothesize
that they can be activated upon the coming set of biosignals which
are transcriptional regulators, leading to the case that different
Figure 5. Dynamic representation of transcriptional regulatory network for apoptosis signaling. Transcription factors and target genes
are shown as nodes and their putative regulatory interactions are drawn as edges.
doi:10.1371/journal.pone.0018889.g005
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in different functions. Taken these together, our analysis provides
significant insights on the potential regulatory interactions among
transcriptional factors and their target genes which is a crucial step
towards quantitative modelling of transcriptional regulatory
networks [121].
In order to assess whether coexpressed genes are more likely to
be coregulated, we estimate p-values of CRMs in individual gene
batteries vs. the corresponding entire pattern of expression
(Table 3). The results show that the estimated p-values values
are similar to those calculated for the background set, implying
that the entire pattern of coexpressed genes behaves more likely
the same as a random background rather than as a set of genes
that share a common regulatory mechanism (see Data S1, sheet
‘CRMs’ and ‘Middle-up TLR’). This supports our assumption
related to the definition of a gene battery. Such preliminary results
indicate that genes that are both coexpressed and functionally
relevant are very likely to be governed by an underlying
transcriptional regulatory program.
Predicting transcriptional regulators of an in vitro
endotoxemia model
In order to assess the stability of our prediction, we applied the
analysis to an in vitro human endotoxin model. Data are extracted
from a culture of peripheral-blood-derived mononuclear cells
stimulated by a high dose of LPS (100 ng/ml) [122]. Clustering
approach reveals that there exist five critical transcriptional
responses. Three of them characterize inflammatory phases similar
to those identified in the analysis of in vivo data including an early-
up response (284 probesets), a late-up response (700 probesets),
and a down regulation (226 probesets). Due to a high dose of LPS
administration, it would have expected an up- (367 probesets) and
a down-regulation (319 probesets) without returning to the base
line after 24 hr of LPS administration. Subsequently, a similar
analysis of pathway enrichment (using KEGG database) was
applied for each set of genes characterizing a transcriptional
response. In an overlap with the analysis of in vivo data, we select
statistically inflammatory relevant significant pathways (p-val-
ue,0.05) that were selected from the analysis on the in vivo human
endotoxemia model. Accordingly, nine sets of genes that belong to
a specific pathway and a pattern of gene expression were
extracted, corresponding to nine genes batteries used to determine
critical transcriptional regulators relevant to the inflammatory
response in this study (Table 4).
Subsequently, the proposed method has been applied to search
for statistical significant CRMs which are decomposed into a list of
TFBSs to infer associated TFs that may be functional transcription
factors in the regulation of inflammatory transcriptional responses.
In a similar manner with the in vivo analysis, TFs that are present
with the high frequency among gene batteries (at least three times)
are reported (Table 4). We identify 27 critical TFs of which more
than 80% are present in the list of relevant transcriptional
regulators found in the analysis of the in vivo data including AP4R,
CLOX, CREB, E2FF, EGRF, EKLF, ETSF, FKHD, HOMF,
HOXF, IRFF, MAZF, NFKB, NKXH, NR2F, OCT1, RXRF,
SORY, SP1F, STAT, TBPF, ZBPF. Given that different dosing
amounts of LPS have been applied in two experiments, there may
be different genes involved in the response of the same function
between the in vivo- and in vitro- model, resulting in different TFs
involved in the transcriptional regulation of the same gene battery
between two cases. However, the significant overlap between two
final lists of predicted TFs relevant to inflammatory transcriptional
responses provides promising implications of the predictive
performance of the method. Therefore, the proposed framework
appears to be a robust and valuable methodology to identify
critical transcriptional regulators relevant to biological responses
under external stimuli (see details in Data S2).
Computational issues
Regarding the computational definition of CRMs, although
taking structural constraints (e.g. the strand orientation, the order,
and the distance between successive TF-binding sites) into account
can reduce the number of false positive matches, a strict definition
of structural constraints can increase the rate of false negative
Table 3. Statistical significance of selected cis-regulatory modules
*.
No. cis- regulatory modules avglen-minlen-maxlen
Common
levels
vs. the background
1
(p-value
3)
vs. the entire pattern
2
(p-value
3)
1 +AP4R__2GATA__2HEAT
$ 288__169__485 0.75 1.88E-06 1.78E-05
2 +E2FF__+MOKF__2E2FF 333.8__170__514 0.75 1.06E-05 9.32E-08
3 +MOKF__2MZF1 168.7__95__236 0.75 3.36E-05 6.37E-07
4 +SP1F__2ETSF__2NFKB 189__110__268 0.75 3.58E-05 1.78E-05
5 +PAX6__+SNAP 154.2__66__260 0.75 4.29E-05 3.82E-05
6 +MOKF__2NKXH 101.3__37__194 0.875 4.51E-05 2.57E-05
7 +PAX6__2ETSF__2ZBPF 271.7__191__326 0.75 4.52E-05 3.82E-05
8 +NKXH__2CREB__2E2FF 518.3__403__788 0.75 6.85E-05 1.35E-04
9 +MAZF__2E2FF 72.1__32__98 0.875 9.82E-05 6.96E-05
10 +NFKB__2CREB__2SP1F 246.2__117__529 0.75 9.91E-05 1.35E-04
*: common significant cis-regulatory modules that are considered as transcriptional regulators for 8 genes in the middle-up expression pattern that belong to the
apoptosis pathway;
‘+’|‘2’ TFBSs present on the forward | backward strand orientation;
$: this CRM contains 3 TFBSs, binding sites of AP4R on the forward and of GATA, HEAT on the backward strand. Its average length is 288 bases while the minimumo n e
has 169 bases and the maximum one has 485 bases. There are 8*0.75=6 instances of this CRM over 8 control regions of 8 genes;
1: the background consists of 5,000 randomly selected genes;
2: the entire corresponding pattern of gene expression (88 genes in this case);
3: hyper-geometric p-value of this group vs. the background set or vs. the entire pattern.
doi:10.1371/journal.pone.0018889.t003
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Usually there is a pre-defined selection in the length (or window
size) and the distance variation between successive binding sites in
the composition of CRMs. However, our analysis excludes these
parameters since a distance variation of several bases or several
hundreds of bases may be invariant in the cells. Instead, we
estimate the CRM length based on the length of its instances
present on the control regions of corresponding genes in order to
select common CRMs and calculate their significance values vs.
the background set. Therefore, there is only one adjustable
parameter (p-value) which defines the significance level of the
resulting CRMs. The statistical significance thresholds for CRMs
are selected following the red curve in Figure 2 which is an
approximation of the blue curve. The fluctuation of the blue curve
is in part due to the random selection of the gene sets as well as due
to the round-up to an integral number of the common level d
(70%) compared to the gene-set size N (e.g. either N is 6 or 7, there
is the same common level for those recognized CRMs – present on
at least 5 genes in this case) (see Data S1, sheet ‘p-value’).
Predicated upon the context-specific nature of the problem as
well as a number of other relevant issues (e.g. establishing the
criteria to measure the performance of the prediction, building up
testing datasets), testing predicted CRMs and/or relevant TFs as
‘true’ or ‘false’ remains a challenge [27]. Thus of critical
importance is to evaluate and validate the computational results
based on literature evidence and those experimentally verified if
possible. In this study, we employed a CRM-searching approach,
similar to FrameWorker method [28], to identify common CRMs
in each gene battery. However, the most critical issue is that a
large proportion of mammalian genes possess multiple transcrip-
tion start sites (TSSs) and therefore multiple alternative pro-
moters regulate gene expression in a context-specific manner
[123,124,125]. For instance, in a recent study Singer et al. [126]
developed and employed a custom microarray platform to show
that there are nearly 35,000 alternative putative promoters present
on around 7,000 human genes. As a result, the computational
identification of CRMs becomes a combinatorial problem and
oftentimes a daunting task due to the large number of alternative
promoters of genes in the gene battery. For example, 7 genes that
belong to Apoptosis pathway and late-up expression pattern can
produce totally 5,600 combinatorial promoter sets; or 10 genes
that are in Cytokine-cytokine pathway and late-up expression
pattern can create 13,440 combinatorial promoter sets; while
complexity further increases in the oxidative phosphorylation
group (down expression pattern) characterized by 40 genes and
1,274,019,840 combinatorial promoter sets. Consequently, search-
ing for common CRMs in all promoter combinations is
computationally intense. Yet, our novelty heuristic can reduce
these complexities into only one running time but still preserve the
same result (see appendix, lemma 1). In a similar manner, the
strategy of converting promoter sequences into promoter profiles
also makes the estimation of the significance of common CRMs vs.
a large background set more computationally tractable [56].
Since it is not clear how long the promoter length should be, our
computational analysis extracts highly qualitatively defined
promoters from Genomatix databases [26] including those with
either an experimentally defined length or a default if there is no
associated prior length information. This default length (500 bp
upstream plus 100 bp downstream the TSSs) is also supported
from a recent experiment known as genome-wide open chromatin
map [127]. Additionally, we also examined how the promoter
length affects the in silico inference of CRMs. Specifically, we count
the number of relevant TFs that can be considered as
transcriptional regulators for the group of 8 genes that belong to
the middle-up expression pattern and the apoptosis pathway. For
each specific length of extracted promoters (27 promoters that are
relevant transcripts; 100*x upstream and 20*x downstream bases,
x from 4 to 10), we applied the same procedure to search for
statistically significant CRMs and then infer the list of relevant
TFs. The results show that the number of relevant TFs increase
linearly with respect to increasing promoter lengths (see Data S1,
sheet ‘Promoter length’). Thus, including prior information of the
promoter lengths is very important to provide reliable computa-
tional predictions.
Another important challenge in computationally identifying TFs
is associated with the fact that transcription factors can bind to
regions far from the TSSs. For example, the P53 factor is a well
established regulator for the programmed cell death (apoptosis)
[128,129]; however such regulator is not identified as putative TF
in the gene batteries relevant to apoptosis pathway. However, if we
increase the promoter length up to approximately 1,000 bp P53 is
identified within the statistically significant CRMs. This leads to
Table 4. Critical transcription factors identified from the in vitro endotoxin study.
No. Patterns Functions Transcription factors
*
1 Early-up Apoptosis CLOX, E2FF, EGRF, EKLF, ETSF, FKHD, HOXC, HOXF, IRFF, MAZF, NKXH, NOLF, OCT1, RXRF, SORY, SP1F, STAT,
XBBF
2 Late-up Apoptosis CREB, EKLF, MAZF, NFKB, SORY, ZBPF
3 Early-up Toll-like receptor signaling
pathway
AP1R, CLOX, E2FF, EGRF, EKLF, ETSF, HOXC, IRFF, NFKB, NOLF, NR2F, OCT1, RXRF, SORY, SP1F, STAT, XBBF, ZBPF
4 Late-up Toll-like receptor signaling
pathway
ABDB, CLOX, ETSF, HOMF, HOXF, IRFF, NFKB, NKXH, RXRF, SORY, STAT, TBPF
5 Early-up Cytokine-cytokine receptor
interaction
CREB, ETSF, FKHD, HOXF, RXRF, STAT, TBPF
6 Late-up Cytokine-cytokine receptor
interaction
ABDB, HOXF, NR2F, OCT1, RXRF, SORY, STAT
7 Early-up Jak-STAT signaling pathway ABDB, AP1R, AP4R, E2FF, EGRF, EKLF, ETSF, FKHD, HOMF, HOXF, IRFF, MAZF, NKXH, RXRF, SORY, SP1F, STAT,
TBPF, XBBF, ZBPF
8 Late-up Jak-STAT signaling pathway ABDB, AP1R, AP4R, CLOX, CREB, E2FF, ETSF, FKHD, HOMF, HOXC, HOXF, NKXH, NR2F, OCT1, RXRF, SORY, TBPF
9 Up-remained Pyrimidine metabolism AP4R, E2FF, EGRF, EKLF, ETSF, FKHD, HOXF, MAZF, NFKB, NKXH, NOLF, NR2F, RXRF, SP1F, XBBF, ZBPF
doi:10.1371/journal.pone.0018889.t004
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other TFs that bind to the distant promoter regions. Alternatively,
it has been recognized that P53 can affect apoptosis via novel
transcription-independent pathways although its role as a
mediator of transcription is well established [130,131,132]. For
instance, apoptosis can still occur when P53 mutants incapable of
acting as transcription regulator are introduced [133,134]. This
indicates the possibility that P53 might not directly regulate the
apoptotic gene batteries as identified from our analysis. Thus,
computational missing P53 as a relevant TF may be a reasonable
result rather than a limitation from our computational analysis;
yet, it is still a question to us in this study. However, since our
analysis only searches for CRMs on the proximal promoters of
genes, it should be acknowledged that we may miss some relevant
transcription factors that bind to the regions far from the TSSs as
well as enhancers that regulate the transcriptional process.
Furthermore, we also analyzed the reasons why no statistically
significant CRM is found in the down-regulated gene batteries of
the oxidative phosphorylation pathway (so-called OXPHOS
group). OXPHOS itself is composed of genes that are coexpressed
across numerous datasets under different conditions [135,136] and
it was proposed as a group of genes that might share a common
regulatory mechanism [137]. However, we did not detect any
complex-specific arrangement of TFBSs although it is highly
enriched by a number of common TFBSs even when the promoter
lengths are increased up to 1,000 bp upstream. Although this
conclusion is similar to the result of a previous study [137], we note
that subunits of each complex in OXPHOS group tend to have
tighter coexpression with subunits of the same complex than
subunits of other complex which is also proposed and discussed
extensively in [137]. Based on the assumption that genes
characterized by tightly coordinated expression levels are more
likely to share common regulatory elements (proposed and
demonstrated in [52]), we assume that genes belonging to the
same complex might share some common set of regulatory signals.
Therefore, we applied the same procedure of finding statistically
significant CRMs on the control regions of those subgroups of
genes including complex I – 17 genes, complex III – 6 genes,
complex IV – 4 genes, and complex V – 13 genes. Eventually, we
identified statistically significant CRMs for each complex from
which relevant transcriptional regulators can be inferred. As a
result, from a promoter analysis standpoint we are highly
confident that subunits of each complex in OXPHOS group are
more likely to be under a common regulatory mechanism rather
than all the genes in the entire group (see Data S1, sheet
‘OXPHOS’). However, from a computational standpoint this
result raised another possibility related to whether a subset of
genes within a gene battery can provide more statistically
significant CRMs than the entire gene battery. Assuming that
the possibility is correct, this raises two questions including: (i) what
is an appropriate size of the subset as well as (ii) how genes in the
subset are selected. In order to address this issue, we make a case-
study by randomly selecting a subset of N genes within the
OXPHOS group (N=17, 6, 4, and 13 respectively) and search for
significant CRMs. The process is repeated 100 times and the
average of minimum significance p-values is calculated. Results
show that for N=4, the average of minimum p-values is
comparable to the one with N genes randomly selected from the
background set (Figure 2). Yet, for the other cases the average of
minimum p-values is less significant than the ones from the
background set, suggesting that random subsets of genes within a
gene battery behave more or less similarly to the case from the
background set. Certainly, some subsets can provide more
significant CRMs than the entire gene battery but how to
interpret those selected subsets and the corresponding results
remains a challenge. Therefore, it should be emphasized that using
prior biological knowledge might overcome some of these
limitations.
Our analysis has attempted to reverse engineer the underlying
regulatory network of the human blood leukocyte response to a
prototypical inflammatory stimulus (endotoxin). Given the tran-
scriptional profiling data of human blood leukocytes, an
elementary set of temporal responses with putative transcriptional
regulators have been identified. A key feature of the analysis is the
exploration of the concept ‘gene battery’ which represents for a
group of genes that are both co-expressed and functional relevant
to identify inflammatory transcriptional regulators using a context-
specific searching approach [38]. Novel heuristics regarding to
challenging issues e.g. eukaryotic genes consist of multiple
alternative promoters leading to a huge computational complexity
are also proposed. In order to provide a systematically unbiased in
silico approach, CRM structural constraints are also adjusted so
that no parameter is required except for the statistical significance
thresholds. Furthermore, our analysis also allows for the
reconstruction of a dynamic temporal regulatory network, making
it a critical enabler for improving our understanding of how the
transcriptional machinery ‘program’ effectively regulates key
cellular processes.
Although no single analysis can identify all transcriptional
regulators involved in a response, it has been demonstrated that
the proposed framework can identify critical TFs that are relevant
to acute inflammatory responses. Despite the fact that many
methods have been proposed in the literature to search for
relevant transcriptional regulators, different approaches explore
different biological assumptions resulting to different sets of
putative TFs which may or may not significantly overlap each
other. Since the true extent of all TFs involved in the regulation of
a complex response under some external stimuli is unknown, these
differences could not be interpreted as the high- or low- accuracy
of the methods. Instead, all of found TFs may be involved in
different processes of the response but because of the limitation of
the hypotheses used by the methods, they may not be recognized
by a certain approach.
Novel methods are still proposed using different analytical
approaches but generally they can be categorized into two main
directions including mRNA expression-based [138,139,140] and
TF binding pattern-based methods [28,29,30,31,36]. The first
direction somehow utilizes the fundamental hypothesis that the
mRNA expression level of TFs is proportional to their protein
concentration but this may not be appropriate especially in higher
eukaryotes since TF activation is often regulated post-translation-
ally and acts somewhat in an independent manner of expression
level. Some methods also require multiple-condition data as the
input which may not be applicable when practical data are only
sampled under one condition/treatment [138,139,140]. In the
meanwhile, a lot of methods following to the latter direction have
been developed e.g. FrameWorker [28], CMA [29], CRE `ME
[30], ModuleMiner [31], CisModule [36], BioMoby [141] etc. of
which ours is among them. These are not limited by the mRNA
expression proportion hypothesis but they are limited by promoter
identification, TF binding profiles, and the underlying assumption
to select the input set of ‘co-regulated’ genes.
In this study, we therefore opt to extend an available
computational tool, FrameWorker, to take into account the fact
that genes of higher eukaryotes contain multiple alternative
promoters exploring the rich information of the Genomatix
database on promoters and TF binding profiles. The underlying
assumption that coexpressed genes are more likely to share some
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has been explored to predict putative functional activation of TFs
in a specific context. These factors make our method become
incomparable or unnecessary to compare with available methods.
However, given the future availability of more complete TF
binding data and other resources, the method could be enhanced
by integrating protein-protein interaction to refine selected CRMs
or using other tools to support the selection of relevant functions
e.g. Pathway-Express [142]. Since each single method or even
each direction always contains its own limitations and advantages,
one possibility in future improvements could be the development
of a framework to obtain a consensus result under diverse
underlying hypotheses from various outputs of different methods.
Methods
Human endotoxemia model and data collection
In vivo data. The data used in this study were generated as
part of the Inflammation and Host Response to Injury Large Scale
Collaborative Project funded by the USPHS, U54 GM621119
[11,143]. Human subjects were injected intravenously with
endotoxin (CC-RE, lot 2) at a dose of 2-ng/kg body weight
(endotoxin treated subjects) or 0.9% sodium chloride (placebo
treated subjects). Following lysis of erythrocytes and isolation of
total RNA from leukocyte pellets [11], biotin-labelled cRNA was
hybridized to the Hu133A and Hu133B arrays containing a total
of 44,924 probesets for measuring the expression level of genes
that can be either activated or repressed in response to endotoxin
at 0 (before treatment), 2, 4, 6, 9, and 24 hr. Data are publicly
available through the GEO Database (#GSE3284). ANOVA
technique (p,10
24) was then applied to filter significantly
differentially expressed probesets, resulting in 3,269 selected
probesets [55]. Average expression profiles of probesets over
replicates for each time-point were used as the final input data for
further analyses [144]. The data have been appropriately de-
identified, and appropriate IRB approval and informed, written
consent were obtained by the glue grant investigators [11].
In vitro data. Isolated from peripheral blood mononuclear
cells collected from three healthy humans, adherent monocytes
were cultured for 10 days in RPMI medium 1640 (20% FBS/L-
glutamine/20 mM Hepes/penicillin/streptomycin/50 ng/ml
macrophage colony-stimulating factor) to generate peripheral-
blood-derived mononuclear cells [122]. These mononuclear cells
were stimulated by 100 ng/ml LPS (Salmonella minnesota R595 ultra
pure LPS; List Biological Laboratories, Campbell, CA) and
sampled at 0 (before stimulation), 2, 4, 8, and 24 hr. Total RNA
was isolated with TRIzol (Invitrogen, Carlsbad, CA) and two
samples for each time-point were analyzed using HG-U133 Plus2
Affymetrix GeneChips producing mRNA expression profiles of
54,675 probesets (#GSE5504). Fold change (fold=2.5) was then
applied to filter significantly differentially expressed probesets,
resulting in 2,892 selected probesets. Average expression profiles of
probesets over replicates for each time-point were used as the final
input data for further analyses [144].
Clustering and selection
Utilizing the concept of the agreement matrix (AM) in
consensus clustering, we recently proposed a novel method to
identify the core set of probesets that are most agreeable in the AM
of which they belong to the same or different patterns of gene
expression [55]. In order to produce the agreement matrix, a
number of different clustering methods along with different
metrics (Euclidean, Manhattan, and Pearson correlation) were
used to reduce the bias and assumption of any specific clustering
method. After identifying the core set of probesets, the AM is
reduced correspondingly to those selected probesets and then the
hierarchical clustering is applied on the reduced AM to produce a
number of gene expression patterns. Subsequently, we applied a
trivial-cluster removal procedure and obtain four significant
patterns of gene expression which are shown to be critical in the
dynamics of acute human inflammation.
Problem definition
In this study, genes that are both coexpressed and functionally
relevant are assumed to belong to the same ‘gene battery’. The
problem of CRM searching can be formalized as follows: given a
set of N putatively coregulated genes G~ gi fg
N
i~1, each of which
contains Ki alternative promoters gi~ proik fg
Ki
k~1 whereas each
promoter is represented by a list of Lik binding sites (‘promoter
profiles’) proik~ bsikl fg
Lik
l~1 and each binding site is a 3-tuple
of corresponding transcription factor name f, position p and
binding orientation o: bsikl~vbs
f
ikl, bs
p
ikl, bso
iklw, find a set of
M cis-regulatory modules (CRMs) cCRM~ crmj
 M
j~1, crmj~
bsjl
 Mj
l~1 that are present as common over a threshold d (70% in
this study) on the set of gene promoters (Mj is the number of
binding sites, yet to be determined, in CRM crmj). The statistical
significance of each commonly recognized CRM vs. a background
set of genes is then estimated selecting only significant CRMs. The
subscripts i, k, l, j indicate the gene number, the promoter number,
the binding site number, and the CRM number respectively. An
illustration of the computational framework is presented in
Figure 6 while more details are discussed in the following section.
Discovery of TFBSs and promoter profiles
Based on a comprehensive database of promoters – Genomatix
[26], a set of transcript-relevant promoters are extracted coupled
with multiple alternative promoters and experimental information
about the promoter length including those with either an
experimentally defined length or a default if there is no associated
prior length information (500 bp upstream plus 100 bp down-
stream the TSSs). MatInspector [20] is then applied to scan for
PWM matches on those promoter sequences using optimal
parameters from MatBase [26]. In order to speed up the process
of discovering CRMs as outlined in [56], each promoter is re-
modelled with a list of Lik TFBSs ordered by their local positions
on the promoter sequences and represented by the corresponding
TF name (e.g. NFKB, ETSF) along with the binding orientation
proik~ bsikl fg
Lik
l~1. The conversion aims to answer two basic
questions: (i) given a promoter sequence, identify whether a TFBS
or a CRM is present on this promoter or not, and (ii) given a gene
with Ki alternative promoters, determine if a TFBS or a CRM is
present on any promoter sequence of this gene. From a
computational standpoint each promoter profile is loaded into a
hash table whose field ‘key’ includes the TFBS name plus the
binding orientation (e.g. +ETSF, 2PAX6, ‘+’ as forward and ‘2’
as backward binding orientation) and field ‘value’ is the position
list of the corresponding TFBS with the same binding orientation.
For example, if the key is ‘+ETSF’ and the corresponding value is
‘373__386’, we know that transcription factor ETSF is forward
binding to the promoter at the local position 2373 or 2386
upstream. As a result, to decide the existence of a TFBS including
the binding orientation on a promoter the process only makes a
quick search in the hash keys. In a similar way, to determine the
present of a CRM on a promoter the process will take into account
the binding orientation from the keys and the positions from the
values of corresponding keys to evaluate the structural constraints
(see Data S1, sheet ‘Promoter profiles’).
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Computationally, a cis-regulatory module crmj is a list of Mj
non-overlapping TFBSs ordered by their positions on the
promoter sequence and characterized with their corresponding
binding strand orientation. For example, CRM ‘+NFKB__
2CREB__2SP1F’ consists of three successive TFBSs of tran-
scription factors NFKB, CREB, SP1F with the binding strand
orientation forward, backward, and backward respectively. Besides
the binding orientation and the position order of TFBSs, CRMs
are also characterized by their length. If CRM A appears to be
common in a gene battery of N genes, the average length of all
instances of A on N genes is considered to be the length of this
CRM. In the case that A presents more than one time on
promoters of gene i, the length of instance A for this gene will be
the minimum one. Subsequently, to estimate the common level of
this CRM we only take into account those instances with the
length approximate to the average one (e.g. from the half to the
double). If the number of such instances over N is higher than a
frequency threshold (d=70% in this study), CRM A is considered
as a common CRM of the gene battery.
However, a gene can have multiple alternative promoters and
virtually in all cases, it is not known which promoter of the gene is
activated. To identify activation of putative promoters, one solution
would be to search for all possible combinations of promoters in the
gene set. Yet given a set of N genes, each gene with K alternative
promoters in average, the total combinatorial number of promoter
sets is K
N which is computationally intense and sometimes
impossible to search for all promoter combinations. Consequently,
we propose a novel heuristic where if a TFBS or a CRM is present on any
promoter sequence of a gene, it is considered as present on the control regions of
that gene. The heuristic results in one-time searching instead of K
N
but still produces the same results as the brute-force search in all
combinations of promoters (see Appendix S1, procedure ‘IsPresent’
in Algorithms S1 and Procedures S1). Using this heuristic, the main
algorithm to search for common CRMs in a gene battery, similar to
FrameWorker [28], can be simply described with two primary steps
as follows: (1) identify all potential TFBSs that are common in a
gene battery and (2) employ the breadth first search technique to
search for all possible combination of all commonly found TFBSs in
step 1, each of which is a potentially common CRM yet to be
determined quickly by the heuristic above (see details in Algorithms
S1 and Procedures S1).
Estimating the statistical significance of cis-regulatory
modules
Due to the fact that a CRM can be present on promoters of
many genes in the background set, we estimate the statistical
significance of commonly identified CRMs for each gene battery
Figure 6. Flowchart of the CRM searching process. Each binding site is characterized by the TF name, position and binding strand orientation (+:
forward and 2: backward).Promoter sequences areconvertedintopromoter profiles to speed up the calculation.Agene profilecontainsa set ofpromoter
profiles that are corresponding to a set of alternative promoters of that gene. The background set contains 5,000 randomly selected human genes.
doi:10.1371/journal.pone.0018889.g006
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overrepresented. Based on promoter profiles, the procedure can
directly identify whether a particular CRM is present on any
promoter sequence of a gene in real-time despite the large
background set of genes. This calculation provides a correspond-
ing hyper-geometric p-value defined as follows:
p{value CRMA ðÞ ~
b
n

B{b
N{n
 
B
N

where B and b is the number of genes and the number of hits
respectively in the background set which is made up of 5,000
randomly selected genes in human genome; N and n is the number
of genes and hits in the gene battery, respectively.
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